Research into metabolic and weight-management peptides focuses on appetite and glucose signalling, insulin sensitivity, and changes in body composition. Below is plain-language reading on what studies have actually examined — with no dosage and no promises.
Metabolic weight-management peptides, such as GLP-1/GIP/glucagon receptor agonists, are studied for their effect on appetite regulation, blood sugar control …
研究中的作用机制Retatrutide 是一种在代谢研究中被研究的三重激素受体激动剂——它同时靶向三种参与食欲和能量调节的受体：GLP-1（胰高血糖素样肽-1）、GIP（葡萄糖依赖性促胰岛素多肽）和胰高血糖素受体。
研究中的作用机制Tesamorelin 是生长激素释放激素（GHRH）的合成版本，其设计目的是刺激人体自身释放生长激素（GH），而非直接提供生长激素。
研究中的作用机制MOTS-c 是一种由线粒体DNA编码的天然存在的肽，被研究用于其在代谢、胰岛素敏感性及细胞能量调节方面的作用。
Want your responses reviewed?
Take the free assessment — a peptide specialist reviews it and follows up.
Start the free assessmentFor educational purposes only · 21+ · Research-use peptides — not for human consumption. This page surfaces research reading by topic; it is not medical advice, makes no treatment recommendation, and contains no dosage guidance. Retatrutide is an investigational (Phase 3) compound and is not FDA-approved.